Cite

HARVARD Citation

    Bullock, A. et al. (2022). A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults. Human psychopharmacology. p. n/a. [Online]. 
  
Back to record